Identification of TMEM106B as a Shared Potential Drug Target for Depression and Stroke Through Comprehensive Genetic Analyses

Documenti analoghi

• Sex Differences in Suicide Attempts: A Cross‐Sectional Study in Patients with First‐Episode and Drug‐Naïve Major Depression Disorder
  di: Yingzhao Zhu, et al.
  Pubblicazione: (2024)
• Risk Factors, Prognosis, Influence on the Offspring, and Genetic Architecture of Perinatal Depression Classified Based on the Depressive Symptom Trajectory
  di: Hisashi Ohseto, et al.
  Pubblicazione: (2024)
• Structural Neuroimaging and Molecular Signatures of Drug‐Naive Depression With Melancholic Features
  di: Lijin Yuan, et al.
  Pubblicazione: (2024)
• Development and Validation of a Prediction Model for Co‐Occurring Moderate‐to‐Severe Anxiety Symptoms in First‐Episode and Drug Naïve Patients With Major Depressive Disorder
  di: Xiao Huang, et al.
  Pubblicazione: (2024)
• MicroRNAs as Regulators of Neuroinflammation in Major Depressive Disorder
  di: Qirui Li, et al.
  Pubblicazione: (2025)